UUID:D395D84F—BDDF-4802-97DE-9472E6851A88

mliiil'liilivliililliiﬁumnumniiﬁliililie“
|I|||||||||||||| l
Illlllllllllllllll|llllll|lllllllllHIHIIIIIIIIIIIIIIIIIII|||||

IlllllllllllllllllllllllllllllllllllllllllllllllllIIIIIIIIIIIIII

a 5 Clinical Case Report
{C b y a (For Collection of Cancerous Tissue)
(La/tum“, pectin/‘11 fmw‘f-MNL c111.
8’00] 3

5*: Manama; cw»?
,m ﬂab/I» informed Consenii

 

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

Nax‘ne of Physician or Study Coordinator

 

tlinical Information]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

_ GENERAL INFORMATION
Date ofglrth (mm/m He! ht Marital Status Race Temggture ‘
_ . Z 5 tf—L E! Single Married \f P/‘A/pym
Gender Weight E] Divorced U Widow Blood Pressure Heart Rate
754 Male 0 Female ’1” 9) lfm I 2 PP
, l, ‘ L.)
HISTORY OF PRESENT ILLNESS

 

Chief Complaints: MWmaﬂ pawn / fez/at
Symptoms: H QWM ox /‘ ”111 @i' W L49 35 ,

Clinical Findings:

 

 

 

Performance Scale (Kamofsky Score):
a 100 Asymptomatic a 80-90 Symptomatic but Fully Ambulatory 60-70 Symptomatic, in bed less than 50% of day
:1 40-50 Symptomatic, in bed more than 50% of day, but 11 bed ridden D 20-30 Bed Ridden

 

 

 

CURRENT MEDICATIONS

 

PAST MEDICAL HISTORY

Date

 

 

 

 

 

 

 

 

 

OBIGYN HISTORY . .
Menopausal Status Date of First Menses # of Pregnancies
El Pro-menopausal
D Peri’Menopausal Date of Last Menses # of Live Births
El Post-menopausal
Birth Control: a Condom El Oral Contraceptive U iUD u Hormone Replacement
El Otherzg_ Therapy:

 

 

 

 

SOCIAL

Alcohol

FAMILY MEDICAL HISTORY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result ¥ 1 Date [' Test Result Date
HIV “PNegative D Positive:____ CEA Ci Negative Ci Positive:

Hep B alNegative D Positive: CA 15-3 El Nggative El Positive:

Hep C h Negative El Positive: CA 19-9 Ei Ngative E3 Positive:
AFP a Negative :1 Positive: PSA El Negative El Positive:

Other: D Negative El Positive: Other: Cl Negative Ci Positive:

B/T Cell Markers:

 

 

DIAGNOSTIC STUDIES

CLINICAL DIAGNOSIS

T2 N M Stage: 22.

 

 

ii'reatment InformatioEi
SURGICAL TREATMENT

Tumor
Detailed
é: «

Nodes

of L Nodes # of I.
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes
Distant Metastasis

Detailed Location

Nodes

 

Pathology Form

 

[Specimen Informatitﬂ

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: __ Datez,
Preserved by: _ __ Date-7
. SPECIMEN TYPE (# of samples provided)
Frozen Paraffin Block BloodlSerum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
1 2 I? 2 e?“ 4
Time to LN2 Time to Formalin Time to LNZ '
xf rﬁ min / Z min min

 

 

 

 

PATHO CAL DESCRIPTION

Tumor
Distance to NAT

Xv!“ m1 1 [2* , r CID

Nodes
#

Distant Metastasis

 

CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM*

Microscopic Appearance:

1.

CELL ,- STRUCTURAL PATTERN

Mosaic Storiform
Necrosis Fibrosis
L Inﬁltration
Vascular Invasion
Clusterizcd '

Formation M
Indian File

      

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2. Cellular features
Squamous L+ Adenornatous + - Sarcomatous + - Lymphomatous + -
Squamoid Cell Glandular cell Round Cell Large Cell
Spindle Cell Cell Stratiﬁcation Fibroblast Small Cell
Kerstin Secretion Osteoblast RS Cell/RS Like
Dcsmosome Intracyt. Vacuole Lipoblast Inﬂam. Cell
Gland formation Myoblast Plasma Cell
Otherwise S eciﬁed:
" it ”7 PM D; 5’5 7 02; F37

 

 

2. Cellular Diﬂ‘erentiarion:
Well Moderately Poor
Y

 

 

 

 

 

 

 

  

3. Nuclear

 

Anise Nucleosis

Nucleolar Prominent

Giant Cell

Mitotic
Nuclear Grade

Histological Diagnosis: '/ I ' M/ 5446 MW

CA4.
Comments: ”I‘M; [Mg @4IPAVF61IQM ggﬁa /[am~a,

m M64441 will

 

Date

*( INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND PATHOLOGIST STAFF FOR RESEARCH USE ONLY).

 

